A detailed history of Granite Shares Advisors LLC transactions in Incyte Corp stock. As of the latest transaction made, Granite Shares Advisors LLC holds 7,896 shares of INCY stock, worth $547,982. This represents 0.36% of its overall portfolio holdings.

Number of Shares
7,896
Previous 9,217 14.33%
Holding current value
$547,982
Previous $558,000 6.63%
% of portfolio
0.36%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$57.33 - $68.61 $75,732 - $90,633
-1,321 Reduced 14.33%
7,896 $521,000
Q2 2024

Aug 01, 2024

BUY
$51.18 - $63.75 $77,844 - $96,963
1,521 Added 19.76%
9,217 $558,000
Q1 2024

Apr 22, 2024

BUY
$56.55 - $66.59 $7,294 - $8,590
129 Added 1.7%
7,696 $438,000
Q4 2023

Jan 30, 2024

SELL
$52.16 - $64.19 $18,099 - $22,273
-347 Reduced 4.38%
7,567 $475,000
Q3 2023

Oct 31, 2023

BUY
$57.77 - $65.93 $457,191 - $521,770
7,914 New
7,914 $457,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Granite Shares Advisors LLC Portfolio

Follow Granite Shares Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.